Literature DB >> 29207749

Cirrhosis of Liver and Diabetes Mellitus: The Diabolic Duo?

Thazhath Mavali Ramachandran1, Aninchent Harayil Rajan Rajneesh2, George Sarin Zacharia2, Rajendran P Adarsh2.   

Abstract

INTRODUCTION: Cirrhosis of the liver and diabetes mellitus are two chronic illnesses with significant impact on the quality of life. Studies from different part of the world have shown the combination to be associated with higher incidence of complications of cirrhosis and reduced survival. However, data on the impact of pre-cirrhotic and post-cirrhotic diabetes on cirrhosis is minimal. AIM: The aim of the study was to determine the complications of cirrhosis patients with and without co-existent DM and to compare the relation between cirrhosis patients with antecedent DM and hepatogenous DM.
MATERIALS AND METHODS: The present prospective study was conducted at a tertiary care hospital in Kerala, India, over a period of three years. Cirrhosis patients with and without diabetes, along with subcategorization as antecedent and hepatogenous diabetes, were studied for various complications and outcome including death. Chi-square and Mann-whitney tests were used for comparing data.
RESULTS: Patients with cirrhosis and diabetes had higher incidence of gall stones (27.6% versus 13.2%; p=0.008) and urinary infection (29.3% versus 7.5%; p=<0.001). Incidence of hepatocellular carcinoma and mortality were similar between the groups. Patients with antecedent diabetes and hepatogenous diabetes were similar with respect to complications and mortality. Child-Turcotte-Pugh (CTP) score, Model for End stage Liver Disease (MELD) score, urinary tract and respiratory infections and duration of cirrhosis were independent predictors of mortality in patients with cirrhosis.
CONCLUSION: Coexistent diabetes mellitus increases the incidence of complications and hospitalizations in cirrhosis patients but without impact on mortality rates. There is no significant morbidity or mortality difference between cirrhotics with antecedent diabetes and hepatogenous diabetes.

Entities:  

Keywords:  Carcinoma; Complications; Hepatocellular; Urinary tract infection

Year:  2017        PMID: 29207749      PMCID: PMC5713771          DOI: 10.7860/JCDR/2017/30705.10529

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  46 in total

1.  Ferritin synthesis in inflammation. I. Pathogenesis of impaired iron release.

Authors:  A M Konijn; C Hershko
Journal:  Br J Haematol       Date:  1977-09       Impact factor: 6.998

2.  Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes.

Authors:  J C Pickup; G D Chusney; S M Thomas; D Burt
Journal:  Life Sci       Date:  2000-06-08       Impact factor: 5.037

Review 3.  The model for end-stage liver disease (MELD).

Authors:  Patrick S Kamath; W Ray Kim
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

4.  Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation.

Authors:  M Merli; F Leonetti; O Riggio; V Valeriano; M C Ribaudo; F Strati; G Tisone; C U Casciani; L Capocaccia; F Sprati
Journal:  Hepatology       Date:  1999-09       Impact factor: 17.425

5.  Increased frequency of gallstones in cirrhotic and non-cirrhotic portal hypertension.

Authors:  S K Sarin; R C Guptan; Shailaja Malhotra
Journal:  J Assoc Physicians India       Date:  2002-04

6.  Non-insulin-dependent diabetes mellitus and elevated serum ferritin level.

Authors:  T B Kaye; A T Guay; D C Simonson
Journal:  J Diabetes Complications       Date:  1993 Oct-Dec       Impact factor: 2.852

7.  Prognostic significance of diabetes in patients with cirrhosis.

Authors:  G Bianchi; G Marchesini; M Zoli; E Bugianesi; A Fabbri; E Pisi
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425

Review 8.  Hepatogenous diabetes. Current views of an ancient problem.

Authors:  Diego García-Compean; Joel Omar Jaquez-Quintana; Héctor Maldonado-Garza
Journal:  Ann Hepatol       Date:  2009 Jan-Mar       Impact factor: 2.400

9.  Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity.

Authors:  A S Petrides; T Stanley; D E Matthews; C Vogt; A J Bush; H Lambeth
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

10.  Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease.

Authors:  Adnan Said; John Williams; Jeremy Holden; Patrick Remington; Ronald Gangnon; Alexandru Musat; Michael R Lucey
Journal:  J Hepatol       Date:  2004-06       Impact factor: 25.083

View more
  4 in total

Review 1.  Hepatogenous Diabetes: A Primer.

Authors:  Preetam Nath; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-05-01

2.  The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice.

Authors:  Dong Wang; Yuhuan Luo; Xiaoxin Wang; David J Orlicky; Komuraiah Myakala; Pengyuan Yang; Moshe Levi
Journal:  Int J Mol Sci       Date:  2018-01-03       Impact factor: 5.923

3.  Diabetes does not increase infection risk or mortality following an infection in patients with cirrhosis and ascites.

Authors:  Lars Bossen; Gitte A Dam; Hendrik Vilstrup; Hugh Watson; Peter Jepsen
Journal:  JHEP Rep       Date:  2019-08-08

Review 4.  Hepatogenous diabetes: Knowledge, evidence, and skepticism.

Authors:  Ramesh Kumar; Diego García-Compeán; Tanmoy Maji
Journal:  World J Hepatol       Date:  2022-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.